NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage biotechnology company developing transformative therapies for the treatment of cancer and rare ...
Detailed price information for Trident Resources Corp (ROCK-X) from The Globe and Mail including charting and trades.
Earnings call NIO posted Q4 2025 revenues of RMB 34.7B, up 75.9% YoY, and achieved its first quarterly profit, with vehicle margin rising to 18.1%. Management reaffirmed 40-50% annual delivery growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results